Home › Companies › LARIMAR THERAPEUTICS INC. › 2023-2024

LARIMAR THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and LARIMAR THERAPEUTICS INC.’s Form 8-K, filed 2024-05-31 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 6Ballot items
  • 114Asset managers
  • 730Fund votes
  • 2024-05-29Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore LARIMAR THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by LARIMAR THERAPEUTICS INC.

These tallies are LARIMAR THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-31 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

LARIMAR THERAPEUTICS INC. — official shareholder meeting results, meeting held 2024-05-29
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Jonathan Leff 40,728,411---- 10,501,0698,332,013 Majority: yes
Elect Director: Jeffrey W. Sherman, M.D., FACP 51,056,220---- 173,2608,332,013 Majority: yes
Proposal 2: Approval, on an advisory basis, of the compensation of the Company's named executive officers in 2023 48,754,0882,352,496122,896 --8,332,013 Majority: yes
Proposal 3: Ratification of Independent Registered Public Accountant 59,557,7432,7351,015 --0 Passed
Proposal 4: Approval of an amendment to the Ninth Amended and Restated Certificate of Incorporation, as amended 50,900,686279,97648,818 --8,332,013 Majority: yes
Proposal 5: Approval of an adjournment of the Annual Meeting 49,740,7061,484,5434,231 --8,332,013 Majority: yes

Source: LARIMAR THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-05-31 — read the filing on EDGAR.

How asset managers voted at the LARIMAR THERAPEUTICS INC. 2023-2024 meeting

Each item below shows how the 114 asset managers that disclosed a LARIMAR THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers in 2023

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 48,754,088AGAINST: 2,352,496

LARIMAR THERAPEUTICS INC.’s own tally for this item (“Proposal 2: Approval, on an advisory basis, of the compensation of the Company's named executive officers in 2023”): 48,754,088 for, 2,352,496 against, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 63,802,017 outstanding shares: 76% for, 4% against (80% of the company cast a for/against vote).

The 114 asset managers below cast 95% of the shares they voted on this item FOR (48,423,978 for, 2,609,496 against).

FOR 95%
FOR: 48,423,978 (94.9%)AGAINST: 2,609,496 (5.1%)NOT VOTED: 1,000 (0.0%)
Largest asset managers voting on “Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers in 2023” at LARIMAR THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)21,231,9740 00For
RA CAPITAL MANAGEMENT, L.P.6,045,3500 00For
Janus Henderson3,931,5280 00For
Vanguard2,366,7520 00For
BlackRock1,797,6783,210 00For
ADAGE CAPITAL PARTNERS GP, L.L.C.1,471,5000 00For
Verition Fund Management LLC1,439,7560 00For
DRIEHAUS CAPITAL MANAGEMENT LLC843,6110 00For
Citadel827,2980 00For
FRED ALGER MANAGEMENT, LLC0825,096 00Against
MANGROVE PARTNERS IM, LLC813,9010 00For
Goldman Sachs795,5240 00For
Altium Capital Management LP695,0000 00For
GEODE CAPITAL MANAGEMENT, LLC686,9830 00For
DAFNA Capital Management LLC656,3730 00For
RTW INVESTMENTS, LP625,9100 00For
Fidelity620,7740 00For
Alyeska Investment Group, L.P.0500,159 00Against
State Street497,359479 00For
Woodline Partners LP480,7530 00For
ALGER FUNDS0468,182 00Against
Point72457,3490 00For
Northern Trust281,067202 00For
Two Sigma267,7500 00For
Renaissance229,5980 00For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

2. Approval of an adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve Proposal 4

CORPORATE GOVERNANCEMajority of the votes cast: yes

97% Majority: yes · of votes cast

FOR 97%
FOR: 49,740,706AGAINST: 1,484,543

LARIMAR THERAPEUTICS INC.’s own tally for this item (“Proposal 5: Approval of an adjournment of the Annual Meeting”): 49,740,706 for, 1,484,543 against, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 63,802,017 outstanding shares: 78% for, 2% against (80% of the company cast a for/against vote).

The 41 asset managers below cast 98% of the shares they voted on this item FOR (5,803,943 for, 109,771 against).

FOR 98%
FOR: 5,803,943 (98.1%)AGAINST: 109,771 (1.9%)
Largest asset managers voting on “Approval of an adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meet” at LARIMAR THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,334,7110 00For
BlackRock817,5360 00For
Altium Capital Management LP695,0000 00For
Fidelity620,2960 00For
ALGER FUNDS468,1820 00For
ALGER PORTFOLIOS200,5440 00For
ALGER INSTITUTIONAL FUNDS153,6100 00For
DRIEHAUS MUTUAL FUNDS88,7270 00For
Charles Schwab083,009 00Against
QUANTITATIVE MASTER SERIES LLC49,7900 00For
RBB FUND, INC.49,6760 00For
Dimensional47,0230 00For
TIAA46,9360 00For
American Century44,9010 00For
BRIDGEWAY FUNDS INC44,0340 00For
Brinker Capital Destinations Trust31,590462 00For
Lincoln Financial2,55421,300 00Against
AIG/SunAmerica12,8250 00For
Equitable12,6970 00For
Northern Trust12,1070 00For
Pacific Life11,1490 00For
Bridge Builder Trust10,7610 00For
John Hancock9,1790 00For
Voya8,6820 00For
Jackson National7,7430 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

3. Approval of an amendment to our Ninth Amended and Restated Certificate of Incorporation, as amended, to reflect Delaware law provisions regarding officer exculpation

CORPORATE GOVERNANCEMajority of the votes cast: yes

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 50,900,686AGAINST: 279,976

LARIMAR THERAPEUTICS INC.’s own tally for this item (“Proposal 4: Approval of an amendment to the Ninth Amended and Restated Certificate of Incorporation, as amended”): 50,900,686 for, 279,976 against, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 63,802,017 outstanding shares: 80% for, 0.5% against (80% of the company cast a for/against vote).

The 41 asset managers below cast 99.9% of the shares they voted on this item FOR (5,908,520 for, 5,194 against).

FOR 99.9%
FOR: 5,908,520 (99.9%)AGAINST: 5,194 (0.1%)
Largest asset managers voting on “Approval of an amendment to our Ninth Amended and Restated Certificate of Incorporation, as amended, to reflec” at LARIMAR THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,334,7110 00For
BlackRock817,5360 00For
Altium Capital Management LP695,0000 00For
Fidelity620,2960 00For
ALGER FUNDS468,1820 00For
ALGER PORTFOLIOS200,5440 00For
ALGER INSTITUTIONAL FUNDS153,6100 00For
DRIEHAUS MUTUAL FUNDS88,7270 00For
Charles Schwab83,0090 00For
QUANTITATIVE MASTER SERIES LLC49,7900 00For
RBB FUND, INC.49,6760 00For
Dimensional47,0230 00For
TIAA46,9360 00For
American Century44,9010 00For
BRIDGEWAY FUNDS INC44,0340 00For
Brinker Capital Destinations Trust32,0520 00For
Lincoln Financial23,8540 00For
AIG/SunAmerica12,8250 00For
Equitable12,6970 00For
Northern Trust12,1070 00For
Pacific Life11,1490 00For
Bridge Builder Trust10,7610 00For
John Hancock9,1790 00For
Voya8,6820 00For
Jackson National7,7430 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

4. Election of Class I Directors for a Three-Year Term Expiring in 2027: Jeffrey W. Sherman, M.D., FACP

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 51,056,220WITHHELD: 173,260

LARIMAR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jeffrey W. Sherman, M.D., FACP”): 51,056,220 for, 173,260 withheld, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 63,802,017 outstanding shares: 80% for, 0.3% withheld (80% of the company cast a for/withheld vote).

The 41 asset managers below cast 100% of the shares they voted on this item FOR (5,913,714 for, 0 against).

FOR 100%
FOR: 5,913,714 (100.0%)
Largest asset managers voting on “Election of Class I Directors for a Three-Year Term Expiring in 2027: Jeffrey W. Sherman, M.D., FACP” at LARIMAR THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,334,7110 00For
BlackRock817,5360 00For
Altium Capital Management LP695,0000 00For
Fidelity620,2960 00For
ALGER FUNDS468,1820 00For
ALGER PORTFOLIOS200,5440 00For
ALGER INSTITUTIONAL FUNDS153,6100 00For
DRIEHAUS MUTUAL FUNDS88,7270 00For
Charles Schwab83,0090 00For
QUANTITATIVE MASTER SERIES LLC49,7900 00For
RBB FUND, INC.49,6760 00For
Dimensional47,0230 00For
TIAA46,9360 00For
American Century44,9010 00For
BRIDGEWAY FUNDS INC44,0340 00For
Brinker Capital Destinations Trust32,0520 00For
Lincoln Financial23,8540 00For
AIG/SunAmerica12,8250 00For
Equitable12,6970 00For
Northern Trust12,1070 00For
Pacific Life11,1490 00For
Bridge Builder Trust10,7610 00For
John Hancock9,1790 00For
Voya8,6820 00For
Jackson National7,7430 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

5. Election of Class I Directors for a Three-Year Term Expiring in 2027: Jonathan Leff

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%WITHHELD 20%
FOR: 40,728,411WITHHELD: 10,501,069

LARIMAR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jonathan Leff”): 40,728,411 for, 10,501,069 withheld, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 63,802,017 outstanding shares: 64% for, 16% withheld (80% of the company cast a for/withheld vote).

The 41 asset managers below cast 100% of the shares they voted on this item FOR (3,652,257 for, 0 against).

FOR 62%ABSTAIN 38%
FOR: 3,652,257 (61.8%)ABSTAIN: 2,261,457 (38.2%)
Largest asset managers voting on “Election of Class I Directors for a Three-Year Term Expiring in 2027: Jonathan Leff” at LARIMAR THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,334,7110 00For
BlackRock00 817,5360Abstain
Altium Capital Management LP695,0000 00For
Fidelity620,2960 00For
ALGER FUNDS00 468,1820Abstain
ALGER PORTFOLIOS00 200,5440Abstain
ALGER INSTITUTIONAL FUNDS00 153,6100Abstain
DRIEHAUS MUTUAL FUNDS00 88,7270Abstain
Charles Schwab00 83,0090Abstain
QUANTITATIVE MASTER SERIES LLC00 49,7900Abstain
RBB FUND, INC.00 49,6760Abstain
Dimensional00 47,0230Abstain
TIAA00 46,9360Abstain
American Century00 44,9010Abstain
BRIDGEWAY FUNDS INC00 44,0340Abstain
Brinker Capital Destinations Trust00 32,0520Abstain
Lincoln Financial00 23,8540Abstain
AIG/SunAmerica00 12,8250Abstain
Equitable00 12,6970Abstain
Northern Trust00 12,1070Abstain
Pacific Life00 11,1490Abstain
Bridge Builder Trust00 10,7610Abstain
John Hancock00 9,1790Abstain
Voya00 8,6820Abstain
Jackson National00 7,7430Abstain

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

6. Ratification of Appointment of PricewaterhouseCoopers LLP as our Independent Registered Public Accounting Firm for the 2024 Fiscal Year

AUDIT-RELATEDCompany result: Passed

Combines 2 wordings of this item as funds reported it.

99.9% Passed · of votes cast

FOR 99.9%
FOR: 59,557,743AGAINST: 2,735

LARIMAR THERAPEUTICS INC.’s own tally for this item (“Proposal 3: Ratification of Independent Registered Public Accountant”): 59,557,743 for, 2,735 against — passed, per its Form 8-K filed 2024-05-31 (Item 5.07). Of all 63,802,017 outstanding shares: 93% for, 0.1% against (93% of the company cast a for/against vote).

The 41 asset managers below cast 100% of the shares they voted on this item FOR (5,913,714 for, 0 against).

FOR 100%
FOR: 5,913,714 (100.0%)
Largest asset managers voting on “Ratification of Appointment of PricewaterhouseCoopers LLP as our Independent Registered Public Accounting Firm” at LARIMAR THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,334,7110 00For
BlackRock817,5360 00For
Altium Capital Management LP695,0000 00For
Fidelity620,2960 00For
ALGER FUNDS468,1820 00For
ALGER PORTFOLIOS200,5440 00For
ALGER INSTITUTIONAL FUNDS153,6100 00For
DRIEHAUS MUTUAL FUNDS88,7270 00For
Charles Schwab83,0090 00For
QUANTITATIVE MASTER SERIES LLC49,7900 00For
RBB FUND, INC.49,6760 00For
Dimensional47,0230 00For
TIAA46,9360 00For
American Century44,9010 00For
BRIDGEWAY FUNDS INC44,0340 00For
Brinker Capital Destinations Trust32,0520 00For
Lincoln Financial23,8540 00For
AIG/SunAmerica12,8250 00For
Equitable12,6970 00For
Northern Trust12,1070 00For
Pacific Life11,1490 00For
Bridge Builder Trust10,7610 00For
John Hancock9,1790 00For
Voya8,6820 00For
Jackson National7,7430 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

Largest LARIMAR THERAPEUTICS INC. shareholders voting in 2023-2024

Ranked by the number of LARIMAR THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 63,802,017 shares outstanding at the time of that meeting.

Top LARIMAR THERAPEUTICS INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 33.28%
2RA CAPITAL MANAGEMENT, L.P. 9.48%
3Janus Henderson 6.16%
4Vanguard 3.71%
5BlackRock 2.82%
6ADAGE CAPITAL PARTNERS GP, L.L.C. 2.31%
7Verition Fund Management LLC 2.26%
8DRIEHAUS CAPITAL MANAGEMENT LLC 1.32%
9Citadel 1.30%
10FRED ALGER MANAGEMENT, LLC 1.29%

Reported LARIMAR THERAPEUTICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

LARIMAR THERAPEUTICS INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock 5.23% 13F
Vanguard Group 4.84% 13F
Goldman Sachs 2.47% 13F
Citadel Advisors 2.02% 13F
Geode Capital 1.36% 13F
Millennium Management 1.23% 13F
State Street 0.99% 13F
Renaissance Technologies 0.79% 13F
Point72 0.69% 13F
Northern Trust 0.46% 13F

Percentages above are of 63,802,017 shares outstanding, as reported by LARIMAR THERAPEUTICS INC. on its Form 10-Q dated 2024-05-07 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LARIMAR THERAPEUTICS INC.’s 10-Q dated 2024-05-07. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At LARIMAR THERAPEUTICS INC.'s shareholder meeting held 2024-05-29, in the 2023-2024 proxy season, 114 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 730 separate fund positions. On the most widely held item on that ballot — Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers in 2023 — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: LARIMAR THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-31.

LARIMAR THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.